34.84
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CAPR?
Forum
Prognose
Aktiensplit
Capricor Therapeutics Inc Aktie (CAPR) Neueste Nachrichten
Roth Capital Maintains Capricor Therapeutics (CAPR) Buy Recommendation - MSN
Top 10 healthcare stocks by forward P/E: From Capricor's 418x to Alignment Healthcare's 48x - MSN
CAPR Stock Gains Steam: Former Capricor Exec Could Become FDA’s Top Gene Therapy Regulator Ahead Of High-Stakes DMD Decision - Stocktwits
CAPR Should I Buy - Intellectia AI
Capricor Therapeutics (CAPR) Leads Healthcare Stocks with High F - GuruFocus
Top 10 Healthcare stocks by forward P/E: From Capricor's 418x to Alignment Healthcare's 48x (XLV:NYSEARCA) - Seeking Alpha
Capricor Therapeutics stock jumps as FDA resumes Deramiocel review - MSN
Short Interest in Capricor Therapeutics, Inc. (NASDAQ:CAPR) Increases By 34.6% - MarketBeat
The Technical Signals Behind (CAPR) That Institutions Follow - Stock Traders Daily
Capricor Therapeutics, Inc. (NASDAQ:CAPR) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Roth MKM Maintains Capricor Therapeutics(CAPR.US) With Buy Rating, Maintains Target Price $43 - Moomoo
Capricor's Former Executive Considered for FDA Biologics Chief - Intellectia AI
CAPR Stock Price, Quote & Chart | CAPRICOR THERAPEUTICS INC (NASDAQ:CAPR) - ChartMill
Capricor Therapeutics (NASDAQ:CAPR) Shares Up 9.7%Should You Buy? - MarketBeat
Q3 2025 Capricor Therapeutics Inc Earnings Call Transcript - GuruFocus
[ARS] CAPRICOR THERAPEUTICS, INC. SEC Filing - Stock Titan
Capricor Therapeutics | DEF 14A: Definitive information statements - Moomoo
Capricor Therapeutics (NASDAQ: CAPR) details 2026 meeting, board elections, pay and Deramiocel deals - Stock Titan
Capricor Therapeutics (CAPR) reports positive phase 3 HOPE-3 data and $318M 2025 cash balance - MSN
Aug Update: Is Capricor Therapeutics Inc stock a value trapMarket Performance Recap & Technical Analysis for Trade Confirmation - baoquankhu1.vn
Capricor Therapeutics, Inc.Common Stock (NQ: CAPR - The Chronicle-Journal
JPMorgan Chase Reduces Stake in Capricor Therapeutics - National Today
JPMorgan Chase & Co. Decreases Stock Position in Capricor Therapeutics, Inc. $CAPR - MarketBeat
12 Health Care Stocks Moving In Tuesday's After-Market Session - Sahm
Aug PreEarnings: Whats the profit margin of Capricor Therapeutics IncQuarterly Profit Summary & Consistent Income Trade Ideas - baoquankhu1.vn
Precision Trading with Capricor Therapeutics Inc. (CAPR) Risk Zones - Stock Traders Daily
Capricor Therapeutics (CAPR) Is Up 7.2% After HOPE-3 Data And PDUFA Update Has The Bull Case Changed? - Sahm
Capricor Therapeutics (CAPR) Valuation After New Deramiocel Data And Upcoming PDUFA Milestone - Sahm
Insider Selling: Capricor Therapeutics (NASDAQ:CAPR) Director Sells 7,529 Shares of Stock - marketbeat.com
Capricor Therapeutics (CAPR) director sells 7,529 exercised shares - Stock Titan
Option exercise and 10b5-1 sales reported by CAPR (NASDAQ: CAPR) - Stock Titan
Capricor Therapeutics (NASDAQ:CAPR) Trading Up 6.6%Here's Why - MarketBeat
Karimah Es Sabar Sells 61,265 Shares of Capricor Therapeutics (NASDAQ:CAPR) Stock - marketbeat.com
Insider Selling: Capricor Therapeutics (NASDAQ:CAPR) Director Sells $1,667,397.05 in Stock - marketbeat.com
Insider Selling: Capricor Therapeutics (NASDAQ:CAPR) CFO Sells 25,000 Shares of Stock - MarketBeat
CAPR SEC FilingsCapricor Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Capricor Therapeutics(CAPR.US) Director Sells US$3.52 Million in Common Stock - Moomoo
Capricor Therapeutics EVP Krasney sells $752k in shares By Investing.com - Investing.com Canada
Capricor Therapeutics director sells $3.5m in shares - Investing.com UK
Capricor Therapeutics director sells $3.5m in shares By Investing.com - Investing.com Australia
Capricor (NASDAQ: CAPR) EVP sells 25K shares after option exercises - Stock Titan
Director at Capricor (NASDAQ: CAPR) sells 115,000 shares via 10b5-1 plan - Stock Titan
CAPR Stock Slumps But Wall Street Reiterates Optimism For Deramiocel Approval - MSN
Capricor Therapeutics (NASDAQ: CAPR) proxy: Board nominees, pay and Nippon Shinyaku deals - Stock Titan
[144] CAPRICOR THERAPEUTICS, INC. SEC Filing - Stock Titan
Capricor Therapeutics Stock Rises Above 50-Day Average - National Today
Capricor Therapeutics (NASDAQ:CAPR) Stock Passes Above 50 Day Moving AverageWhat's Next? - MarketBeat
Insider Sell: Is Capricor Therapeutics Inc stock a good dividend stock2026 Price Momentum & Safe Capital Preservation Plans - baoquankhu1.vn
Value Recap: Is Capricor Therapeutics Inc a defensive stock2026 Levels & Weekly High Potential Stock Alerts - baoquankhu1.vn
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):